NCT07206693View on ClinicalTrials.gov

Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation

CompletedOBSERVATIONAL
Enrollment

257,275

Participants

Timeline

Start Date

January 1, 2007

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Prostate CancerProstate Cancer ScreeningProstate Cancer Screening DecisionProstate Specific Antigen Screening
Interventions
DIAGNOSTIC_TEST

Prostate specific antigen (PSA)

Prostate specific antigen (PSA) for prostate cancer screening

Trial Locations (1)

Unknown

Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT07206693 - Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation | Biotech Hunter | Biotech Hunter